24 hour contact: 020 7387 8134
The RVC is a leading, internationally recognised centre for veterinary oncology offering advanced cancer treatments for dogs and cats.
To complement our service we also work closely together with other oncology centres that have radiotherapy facilities to be able to offer the most appropriate treatment modality to our patients at all times.
Temporary closure of service
We are temporarily closing our existing oncology service from July 1st 2019 until 1st February 2020, and as such we are not currently accepting any new oncology cases, other than new surgical oncology cases that we are very happy to continue to see via the Soft Tissue Surgery service.
If you have any queries about this please contact firstname.lastname@example.org
We apologise for any inconvenience caused and look forward to re-launching the full Oncology service in February 2020.
Here at the RVC, we understand that a diagnosis of cancer can be both a frightening and confusing time for many pet owners. We recognise that pet owners have to make many difficult decisions regarding management and treatment options; it is our job as oncologists to appropriately guide our clients through these challenging choices to help make the best possible decision for their pets’ quality of life.
Our oncology team of specialised vets and nurses treat and manage a wide range of oncological problems and regularly liaise with members of other RVC services such as soft tissue surgery, medicine or emergency and critical care to assure the best possible treatment choice for the individual patient is made. We use the most advanced imaging techniques and image-guided sampling to allow us to provide a definitive diagnosis and accurate assessment of the extension of the disease in order to provide our clients with the most informed treatment choices for their companion.
Our veterinary oncologists strive to provide individualised medical care for animals with cancer; in addition to a wide range of chemotherapeutics we offer novel cancer treatments including molecular targeted therapy, metronomic therapy and immunotherapy.
The team are always prepared to discuss cases with professional colleagues and as such are happy to answer any enquiries you may have.